Lung Cancer

First-Line Nivolumab Alone and Combined With Platinum-Based Chemotherapy in Advanced NSCLC

The phase I CheckMate 012 study examined the effects of nivolumab monotherapy and nivolumab combined with platinum-based doublets as first-line treatments in patients with...

Issues in Oncology

ASCO and AACI Initiative to Reduce Administrative and Regulatory Burden in Cancer Clinical Trials

As reported in the Journal of Clinical OncologyJulie M. Vose, MD, MBA, FASCO, of the University of Nebraska Medical Center, Omaha, and colleagues have provided...

Head and Neck Cancer

Testosterone Therapy May Be Cardioprotective in Patients Undergoing Chemotherapy

The anabolic hormone testosterone may lessen the early adverse cardiovascular effects of chemotherapy and chemoradiation for advanced or recurrent cancer, according to a randomized...


More Top Stories

Hepatobiliary Cancer

Ghassan K. Abou-Alfa, MD, on Sorafenib and Doxorubicin for Advanced Hepatocellular Carcinoma


Early Relapse in Follicular Lymphoma: Clinical Trial Data May Guide Management Decisions

Approximately 20% of patients with follicular lymphoma will relapse within 2 years of diagnosis. Although the optimal management of these patients has not been established, clinicians may be guided by data from recent clinical trials, according to Nathan H. Fowler, MD, Associate Professor and...


Nonwhite Organ Transplant Recipients Also at Heightened Risk for Skin Cancer

A new study from Drexel University College of Medicine suggests all organ transplant recipients, regardless of race, should receive routine, total-body screenings for skin cancer.

Out of 259 nonwhite transplant recipients who were evaluated in the study, 19 skin cancer lesions were identified in...

Palliative Care
Supportive Care
Hematologic Malignancies

Areej El-Jawahri, MD, on Hematologic Malignancies: Integrating Palliative Care in Treatment

Skin Cancer

Clinical Trials Actively Recruiting Patients With Basal Cell Carcinoma

Study Title: Long-Pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma (BCC)

Study Type: Interventional/single-group assignment

Study Sponsor and Collaborators: University of California, San Diego; Massachusetts General Hospital

Purpose: To evaluate the safety and efficacy of laser...

President Obama Names Margaret Spitz, MPH, to National Cancer Advisory Board

Margaret Spitz, MPH, Professor in the National Cancer Institute (NCI)-designated Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, has been appointed by President Barack Obama as a member of the National Cancer Advisory Board (NCAB).

A renowned expert in molecular...

High-Calcium, Low-Lactose Diet May Reduce Risk of Ovarian Cancer in African American Women

Research from Rutgers Cancer Institute of New Jersey and and other U.S. health and academic institutions shows a diet high in calcium and low in lactose may reduce the risk of ovarian cancer in African American women. The work, published by Qin et al in the British Journal of Cancer, also found sun ...

Pancreatic Cancer

John P. Neoptolemos, MD, PhD, on Pancreatic Ductal Adenocarcinoma: Results of the ESPAC-4 Trial

ASCO University® Essentials Subscription Now Provided to CancerLinQTM Practices

CancerLinQ LLC, a wholly owned nonprofit subsidiary of ASCO, has announced an exciting new benefit for practices participating in CancerLinQ™. Current and future early adopters of CancerLinQ who sign up before
ASCO’s 2017 Annual Meeting will receive a complimentary subscription to ASCO University...


Comparison of Second-Line Treatments in Advanced Pancreatic Cancer After Gemcitabine-Based Chemotherapy

In the Canadian phase III PANCREOX trial reported in the Journal of Clinical Oncology, Gill et al found no benefit of modified FOLFOX6 (infusional fluorouracil [5-FU], leucovorin, and oxaliplatin) vs infusional 5-FU/leucovorin as second-line treatment in patients with advanced pancreatic cancer who ...

click me